Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OTTMUSG00000019001 Inhibitors

Inhibiting the protein ovary testis transcribed involves a multifaceted approach targeting various cellular signaling pathways and enzymatic activities. The inhibitors Staurosporine, LY294002, Wortmannin, Dasatinib, Erlotinib, Imatinib, and Lapatinib are key players in this process due to their roles in targeting specific proteins and pathways that regulate or influence the activity of ovary testis transcribed. Staurosporine's broad-spectrum inhibition of protein kinases can prevent phosphorylation, an essential post-translational modification necessary for the activation or functional modification of ovary testis transcribed. LY294002 and Wortmannin, both PI3K inhibitors, disrupt signaling pathways critical for the activity of ovary testis transcribed, leading to its functional inhibition. This disruption illustrates the significance of the PI3K pathway in regulating processes that ovary testis transcribed may be involved in.

Furthermore, Rapamycin targets the mTOR pathway, directly impacting protein synthesis and cellular growth processes, vital for ovary testis transcribed's function or post-translational modifications. Inhibitors like PD98059, SB203580, SP600125, and U0126, which target the MAPK/ERK, p38 MAPK, and JNK pathways, respectively, are involved in various cellular processes, including stress responses and regulation, likely important for ovary testis transcribed's functionality. By inhibiting these pathways, these chemicals lead to a decrease in the functional activity of ovary testis transcribed. Erlotinib, Imatinib, and Lapatinib, as tyrosine kinase inhibitors, further contribute to the inhibition by targeting EGFR, BCR-ABL, c-Kit, PDGFR, and HER2/neu. The inhibition of these kinases leads to a reduction in the functional activity of ovary testis transcribed by disrupting the signaling cascades crucial for its functional state. The collective action of these inhibitors, through their specific targets, contributes to the functional inhibition of ovary testis transcribed, demonstrating the intricate interplay between cellular signaling pathways and protein functionality.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine inhibits protein kinases, likely impacting the phosphorylation essential for ovary testis transcribed's activation or functional modification.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, disrupting signaling pathways crucial for ovary testis transcribed's activity, leading to functional inhibition.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits the mTOR pathway, impacting protein synthesis and growth processes vital for ovary testis transcribed's function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits MEK in the MAPK/ERK pathway, potentially reducing ovary testis transcribed's activity by lowering ERK activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAPK, affecting stress response pathways and reducing ovary testis transcribed's functional activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK, impacting cellular processes and reducing ovary testis transcribed's functional activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 inhibits MEK1/2 in the MAPK/ERK pathway, potentially reducing ovary testis transcribed's activity by affecting downstream targets.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, disrupts signaling pathways, leading to functional inhibition of ovary testis transcribed.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib inhibits tyrosine kinases, reducing ovary testis transcribed's activity by affecting relevant signaling pathways.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Erlotinib inhibits EGFR tyrosine kinase, essential for ovary testis transcribed's function, leading to reduced activity.